The first and only overactive bladder treatment in its class
If you’re dealing with urges, frequency, and leaks, ask your healthcare professional (HCP) if Myrbetriq® (mirabegron) may be an appropriate treatment option for you.
Myrbetriq (meer-BEH-trick) is a prescription medicine approved by the FDA (Food and Drug Administration) to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage in adults.
Myrbetriq is the first and only drug in its class for OAB.
Evaluated in clinical studies
The efficacy and safety of Myrbetriq have been evaluated in three 12‑week studies and one long‑term (12-month) safety study.
In clinical trials, Myrbetriq was shown to be effective in treating symptoms of OAB within the first several weeks. Those taking Myrbetriq made fewer trips to the bathroom and had fewer leaks than those not taking Myrbetriq. Your results may vary.
If you have the overactive bladder symptoms of urgency, frequency and leakage, speak up and ask your doctor if Myrbetriq may be right for you.